Dyslipidaemia, inflammation and endothelial dysfunction in diabetes mellitus

International Congress Series

Volumn 1262, Issue C, 2004, Pages 511-514

  Tan, Kathryn ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetes mellitus; Dyslipidaemia; Endothelial dysfunction; Inflammation

Indexed keywords

EID: 18744411020     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2003.11.028     Document Type: Article

References (15)

1. T.J. Anderson Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction Heart Fail. Rev. 8 1 2003 71 86
2. L. Rodriguez-Manas J. Angulo C. Peiro Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats Br. J. Pharmacol. 123 8 1998 1495 1502
3. P. Clarkson D.S. Celermajer A.E. Donald Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels J. Am. Coll. Cardiol. 28 3 1996 573 579
4. G.F. Watts S.F. O'Brien W. Silvester J.A. Millar Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia Clin. Sci. (Lond.) 91 5 1996 567 573
5. M. Greaves R.G. Malia K. Goodfellow Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study Diabetologia 40 6 1997 698 705
6. M. Koga M. Otsuki M. Kubo J. Hashimoto S. Kasayama Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus Diabet. Med. 15 8 1998 661 667
7. C.D. Stehouwer J. Lambert A.J. Donker V.W. van Hinsbergh Endothelial dysfunction and pathogenesis of diabetic angiopathy Cardiovasc. Res. 34 1 1997 55 68
8. K.C. Tan V.H. Ai W.S. Chow Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes J. Clin. Endocrinol. Metab. 84 9 1999 3212 3216
9. K. Kugiyama H. Doi T. Motoyama Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries Circulation 97 25 1998 2519 2526
10. M. Evans R.A. Anderson J. Graham Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus Circulation 101 15 2000 1773 1779
11. K.C. Tan W.S. Chow S.C. Tam Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus J. Clin. Endocrinol. Metab. 87 2 2002 563 568
12. K.C. Tan N.M. Wat S.C. Tam C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance Diabetes Care 26 8 2003 2323 2328
13. C.G. Schalkwijk D.C. Poland W. van Dijk Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation Diabetologia 42 3 1999 351 357
14. C.D. Stehouwer M.A. Gall J.W. Twisk Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death Diabetes 51 4 2002 1157 1165
15. V. Pasceri J.T. Willerson E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 18 2000 2165 2168